TLDR
- A federal appeals court upheld the dismissal of the DOJ criminal case tied to the 737 MAX crashes, removing a key legal overhang for Boeing
- Boeing secured a $326M U.S. Army contract for six CH-47F Block II helicopters, adding to defense backlog
- The Pentagon announced a framework seven-year deal with Boeing and Lockheed Martin to triple PAC-3 MSE missile seeker production capacity
- Boeing Australia and Rheinmetall are jointly offering autonomous combat aircraft to Germany, opening a new export opportunity
- Q1 2026 earnings are set for April 22; analysts expect a loss, and Wall Street carries a Moderate Buy consensus with an average target of $248.86
Boeing had a busy week, and the market noticed. The stock jumped 5.2% on Tuesday after a string of positive developments gave investors something to work with.
The biggest driver was a legal one. A federal appeals court upheld a lower-court ruling to dismiss the DOJ criminal case tied to the 737 MAX crashes. That case had hung over Boeing for years, and its removal cleared a real piece of uncertainty from the stock’s valuation.
The broader market helped too. The Dow surged over 1,100 points as stocks rallied into Q1’s close, giving aerospace names like Boeing an added tailwind.
On the defense side, Boeing picked up a $326 million firm-fixed-price contract from the U.S. Army for six CH-47F Block II remanufactured helicopters. The deal adds to Boeing’s defense backlog and supports near-term cash flow.
Then came the Pentagon announcement. On Wednesday, the U.S. Department of Defense confirmed a framework seven-year agreement with Boeing and Lockheed Martin to triple production capacity for Patriot Advanced Capability-3 Missile Segment Enhancement seekers. That’s a meaningful long-term commitment for Boeing’s defense business.
Boeing Australia also made news, teaming up with Rheinmetall to pitch autonomous combat aircraft to Germany. It’s an early-stage opportunity, but it signals Boeing’s push to diversify its defense revenue internationally.
On the commercial side, new orders from Vietnam carriers were flagged in coverage this week, with analysts pointing to a growing commercial backlog that supports Boeing’s medium-term delivery outlook.
Wall Street Takes a Mostly Positive Stance
Analyst sentiment is broadly constructive. The consensus rating sits at Moderate Buy, with an average price target of $248.86 — well above where the stock is currently trading.
UBS has a Buy rating and a $285 price target. Royal Bank of Canada rates it Outperform with a $275 target. Susquehanna is Positive at $280. Of 25 analysts tracked, 16 carry Buy ratings, five are Hold, and three are Sell.
One analyst, Zacks, moved from Strong Sell to Hold in December — a sign even the bears are stepping back.
Boeing’s last reported quarter was a strong one. The company posted EPS of $9.92 against a consensus estimate of a $0.40 loss, and revenue of $23.95 billion beat estimates by over $1.5 billion. That was a 57.1% jump in revenue year-over-year.
Despite that beat, analysts still model a full-year EPS of -2.58, so the path back to profitability isn’t clean.
Insider and Institutional Activity
Director Mortimer J. Buckley bought 2,230 Boeing shares at $224.20 in early March, more than doubling his position. On the other side, SVP Ann M. Schmidt sold 6,281 shares at $243.37 in February. Insiders have sold around 21,012 shares worth roughly $4.98 million over the past 90 days.
Institutional holders including Vanguard, Geode Capital, and Fisher Asset Management all increased their positions in Q4. Institutional investors now own 64.82% of the stock.
One Cloud Still Overhead
Not everything is positive. NASA is reportedly considering reducing Boeing’s role on the SLS rocket for the Artemis moon program. That would cut long-term space revenue and is a headwind for that business line.
Boeing’s debt-to-equity ratio remains elevated at 8.37. The Q1 2026 earnings call on April 22 will be watched closely for updates on margins, deliveries, and cash flow.







